Navigation Links
A novel treatment may reduce myocardial infarction size
Date:2/27/2014

Researchers at the University of Eastern Finland (UEF) have developed a novel treatment for myocardial infarction. In a study carried out at the UEF, virus vectors were used in a mouse model to deliver small RNA molecules into the heart, and this significantly reduced the size of myocardial infarction. In the novel treatment method, RNA molecules are targeted at the regulatory area of the vascular endothelial growth factor gene (VEGF-A). These molecules use epigenetic mechanisms to enhance the production of the growth factor in cells.

The study also focused on the mechanisms of this new treatment, epigenetherapy, in cell models. The study was carried out in collaboration between researchers of the MRI Research Group at the A.I. Virtanen Institute for Molecular Sciences at the UEF, the University of Jyvskyl, and Temple University in Philadelphia. The study was published in PLOS ONE on 26 February.


'/>"/>
Contact: Seppo Ylä-Herttuala
seppo.ylaherttuala@uef.fi
358-403-552-075
University of Eastern Finland
Source:Eurekalert

Page: 1

Related medicine news :

1. A new target for cancer and diabetes: A novel role for the adaptor protein p66shc in regulating glucose metabolism
2. Novel compound keeps Parkinsons symptoms at bay in mice
3. New company to develop novel gene therapies
4. Novel technique increases detection rate in screening mammography
5. Researchers find novel approach for controlling deadly C. difficile infections
6. Novel genes determine division of labor in insect societies
7. Novel biomarker approach suggests new avenues to improve schizophrenia disease management
8. Development of a novel dual JAK/Src kinase inhibitor
9. Jesus Was Not Born On December 25th - Controversial New Novel Tells Compelling Story About His Birth, Life and Death
10. Fatigue, a common side effect of breast cancer treatment, evaluated in novel patient study
11. Novel drug regimen can improve stem cell transplantation outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... May 29, 2015 Dr. Rodger ... Chronic Fatigue Syndrome is now offering free weekly ... learn about natural ways to reduce symptoms associated ... poor sleep, and brain fog. , To ... and Beating Fibromyalgia call in teleconferences simply go ...
(Date:5/29/2015)... 2015 Javlin continues to fulfill its ... and a larger team, with the intention to better ... share in the U.S. and Canada. , Javlin Inc., ... significant growth in 2014 with its strongest earnings to ... integration platform, CloverETL. To accelerate further progress and ensure ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 The ... has transformed the science of the little-known and ... it is co-funding the second FSHD Trial Preparedness ... 2015, at the University of Rochester Medical Center ... 50 stakeholders from around the world, including representatives ...
(Date:5/29/2015)... 2015 Health DataPalooza is a national ... discuss and foster the most effective and innovative ways ... Conference is hosted by the Health Data Consortium, which ... to promote and develop the use of open healthcare ... groups to narrow in on how to actually put ...
(Date:5/29/2015)... An organizational consultant and part-time college ... his memory and may be suffering from early dementia. ... professional life and in his uncertain relationship with his ... career working with corporate and government movers and shakers ... family members around him are being diagnosed with Alzheimer’s, ...
Breaking Medicine News(10 mins):Health News:Growth of Data Integration Platform CloverETL Continues in North America 2Health News:International Conference Brings Together Key Stakeholders to Advance Clinical Trial Readiness for FSHD 2Health News:International Conference Brings Together Key Stakeholders to Advance Clinical Trial Readiness for FSHD 3Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 2Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 3Health News:‘Forgetful’ Professor Struggles With Dementia in Compelling New Novel 2
... INC. (NYSE: RMD ),announced today that on Thursday, ... second quarter of fiscal year 2008, ended December 31,2007. ... p.m. Pacific,Time and will host a conference call to ... The conference call is scheduled to begin at 1:30 ...
... Board,Company (Nasdaq: ABCO ) announced today that it ... Williams, Chairman and Chief Executive,Officer, and Michael T. Kirshbaum, ... the quarter ended December 31, 2007. The,call will be ... Eastern Time.,The Company plans to release its third quarter ...
... QC, Jan. 24 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: ... into a licensing and,distribution agreement with iNova Pharmaceuticals ... Australia., "Building on the launch of our ... continue to add strong distribution partners as we,prepare ...
... Jan. 24 Align,Technology, Inc. (Nasdaq: ALGN ... method of straightening teeth without wires or brackets, ... and launched a new, interactive web site to ... programs to meet the experience,level of almost every ...
... BRCA mutations would be more willing to test their own ... most U.S. medical groups are opposed, many people support genetic ... breast and/or ovarian cancer later in life, a new study ... Center in Philadelphia, and her colleagues interviewed 53 people ...
... HIV/AIDS Patients in Broward County and,Statewide, Community Open ... Testing, FT. LAUDERDALE, Fla., Jan. 24 AIDS,Healthcare ... ,Out of the,Closet, thrift store and ,AHF Pharmacy, location ... on Saturday, January 26th at 10:00 a.m. This,festive community ...
Cached Medicine News:Health News:RESMED to Webcast Second Quarter 2008 Earnings Conference Call 2Health News:The Advisory Board Company Schedules Third Quarter Investor Conference Call for February 5, 2008 2Health News:Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova 2Health News:Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova 3Health News:Align Technology Launches Aligntech Institute to Help Invisalign Providers Enhance Treatment Success and Practice Economics 2Health News:Align Technology Launches Aligntech Institute to Help Invisalign Providers Enhance Treatment Success and Practice Economics 3Health News:Next Generation of Parents More Likely to Back Genetic Testing 2Health News:AIDS Healthcare Foundation Hosts Grand Opening of Wilton Manors 'Out of the Closet' & 'AHF Pharmacy' 2Health News:AIDS Healthcare Foundation Hosts Grand Opening of Wilton Manors 'Out of the Closet' & 'AHF Pharmacy' 3
(Date:5/28/2015)... ZURICH , May 28, 2015  Maetrics ( ... the life sciences sector, wrapped up a successful conference, ... the Medical Technology industry," today in Zurich ... ( http://www.maetrics.ch ) and its Switzerland ... regulation on the Medical Technology field to an exclusive ...
(Date:5/28/2015)... 28, 2015 The controversy surrounding the ... and myomectomies (procedures to remove uterine fibroids) continues, ... is investigating Johnson & Johnson,s Ethicon, Inc. unit, ... devices. According to the report published by The ... the FBI is trying to determine what the ...
(Date:5/28/2015)... 28, 2015 Isis Pharmaceuticals, Inc. (NASDAQ: ... WebcastWhen: , Thursday, June 4 at 1:00 p.m. ET ... Live on the Internet.  Simply log onto our website ... the live event, a replay of the webcast will ... . ABOUT ISIS PHARMACEUTICALS, INC. Isis is ...
Breaking Medicine Technology:Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 3Webcast Alert: Akcea Therapeutics Conference Call 2Webcast Alert: Akcea Therapeutics Conference Call 3
... 2011 Valeant Pharmaceuticals International, Inc. (NYSE: ... March 10, 2011, the company completed its previously ... About Valeant Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ... manufactures and markets a broad range of pharmaceutical ...
... Inc. (Nasdaq: GNVC ) announced financial results for ... the year ended December 31, 2010, the Company reported a ... with a net loss of $18.4 million, or $0.19 per ... the year with $35.2 million in cash, cash equivalents, and ...
Cached Medicine Technology:GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 2GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 3GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 4GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 5GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 6GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 7GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 8
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: